Latest AI and machine learning research in skin cancer for healthcare professionals.
Melanoma is still a major health problem worldwide. Early diagnosis is the first step toward reducin...
Cancer stands as the leading global cause of mortality, with rare cancer comprising 230 distinct sub...
BACKGROUND: Bladder cancer (BCa) is a common malignancy of the urinary tract. Due to the high hetero...
Breast cancer is the most prevalent and heterogeneous form of cancer affecting women worldwide. Vari...
Cancer vaccines have been increasingly studied and developed to prevent or treat various types of ca...
Immuno-oncology holds promise for transforming patient care having achieved durable clinical respons...
Using the particular nature of melanoma mutanomes to develop medicines that activate the immune syst...
BACKGROUND: Robot-assisted pelvic lymph node dissection (rPLND) has been reported in heterogenous gr...
The incidence of melanoma is increasing rapidly. This cancer has a good prognosis if detected early....
Immunotherapy is an emerging treatment method aimed at activating the human immune system and relyin...
The advancement in cancer research using high throughput technology and artificial intelligence (AI)...
BACKGROUND: Deep-learning convolutional neural networks (CNNs) have outperformed even experienced de...
Machine Learning (ML) techniques provide the ability to effectively evaluate and analyze human skin ...
The inferences of most machine-learning models powering medical artificial intelligence are difficul...
Over the past few decades, skin cancer has emerged as a major global health concern. The efficacy of...
Background and objective The risk of malignant melanoma (MM) and other forms of skin cancer appears ...
The cellular immune response comprises several processes, with the most notable ones being the bindi...
Since US Food and Drug Administration approval of programmed death ligand 1 (PD-L1) as the first com...
INTRODUCTION: Pancreatic cancer (PC) has an extremely poor prognosis, even with surgical resection a...
When the mutation affects the melanocytes of the body, a condition called melanoma results which is ...
INTRODUCTION: Combination immunotherapy holds promise for improving survival in responsive glioblast...